SMTL ID : 5l2w.1

The X-ray co-crystal structure of human CDK2/CyclinE and Dinaciclib.

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.80 Å

Oligo State

hetero-1-1-mer

Ligands

1 x 1QK: 3-[({3-ethyl-5-[(2S)-2-(2-hydroxyethyl)piperidin-1-yl]pyrazolo[1,5-a]pyrimidin-7-yl}amino)methyl]-1-hydroxypyridinium(Non-covalent)

1QK.1: 18 residues within 4Å: Chain A: I.11, E.13, G.14, V.19, A.32, F.81, E.82, F.83, L.84, H.85, Q.86, D.87, K.90, Q.132, N.133, L.135, A.145, D.146 11 PLIP interactions: 11 interactions with chain A Hydrophobic interactions: A:I.11, A:I.11, A:V.19, A:A.32, A:F.81, A:F.83, A:L.135, A:L.135 Hydrogen bonds: A:L.84, A:L.84, A:D.146

1 x GOL: GLYCEROL(Non-functional Binders)

GOL.2: 6 residues within 4Å: Chain A: H.85, Y.108, I.136, N.137, T.138, G.140 5 PLIP interactions: 5 interactions with chain A Hydrogen bonds: A:H.85, A:Y.108, A:Y.108, A:T.138, A:G.140

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Chen, P. et al., Spectrum and Degree of CDK Drug Interactions Predicts Clinical Performance. Mol.Cancer Ther. (2016)

Release Date

2016-08-24

Peptides

Cyclin-dependent kinase 2: A
G1/S-specific cyclin-E1: B

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

Cyclin-dependent kinase 2

G1/S-specific cyclin-E1

Related Entries With Identical Sequence